Cargando…
Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are a useful source for cell-based therapy of a variety of immune-mediated diseases, including neurodegenerative disorders. However, poor migration ability and survival rate of MSCs after brain transplantation hinder the therapeutic effects in the disease microenvironme...
Autores principales: | Lee, Na-Hee, Myeong, Su Hyeon, Son, Hyo Jin, Hwang, Jung Won, Lee, Na Kyung, Chang, Jong Wook, Na, Duk L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583833/ https://www.ncbi.nlm.nih.gov/pubmed/32977637 http://dx.doi.org/10.3390/ijms21197013 |
Ejemplares similares
-
Intrathecal Injection in a Rat Model: A Potential Route to Deliver Human Wharton’s Jelly-Derived Mesenchymal Stem Cells into the Brain
por: Kim, Hyeongseop, et al.
Publicado: (2020) -
Preclinical assessment of thrombin‐preconditioned human Wharton’s jelly‐derived mesenchymal stem cells for neonatal hypoxic‐ischaemic brain injury
por: Noh, Jung‐Ho, et al.
Publicado: (2021) -
Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma
por: Hwang, Jung Won, et al.
Publicado: (2021) -
Wharton's Jelly-Derived Mesenchymal Stem Cells with High Aurora Kinase A Expression Show Improved Proliferation, Migration, and Therapeutic Potential
por: Kim, Sun Jeong, et al.
Publicado: (2022) -
The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)